The collaboration leverages NetTargets’ AI platform and Debiopharm’s MLINK technology to create cancer treatments. Credit: THICHA SATAPITANON/Shutterstock.com ...

Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study ...

Combination therapies, which use multiple drugs to target different pathways involved in disease, are increasingly critical for treating complex conditions such as cancer. However, the process of ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of ...

Spinal cord injury remains one of the most challenging neurological conditions to treat, largely because damage continues to worsen long after the initial trauma. Secondary injury processes—driven by ...

A computational tool has accurately predicted a drug combination that inhibited triple-negative breast cancer in in vitro experiments. Researchers at the Icahn School of Medicine at Mount Sinai (NY, ...

Cancer remains a leading cause of global mortality, with therapeutic challenges primarily arising from drug resistance and limited treatment efficacy. Polypharmacology—the strategic use of ...